197 related articles for article (PubMed ID: 30066876)
61. Emodin Inhibits Breast Cancer Growth by Blocking the Tumor-Promoting Feedforward Loop between Cancer Cells and Macrophages.
Iwanowycz S; Wang J; Hodge J; Wang Y; Yu F; Fan D
Mol Cancer Ther; 2016 Aug; 15(8):1931-42. PubMed ID: 27196773
[TBL] [Abstract][Full Text] [Related]
62. ERO1L Promotes Hepatic Metastasis through Activating Epithelial-Mesenchymal Transition (EMT) in Pancreatic Cancer.
Yang J; Xu Y; Huo Y; Cai L; Hua R; Zhang J; Chen Z
J Immunol Res; 2021; 2021():5553425. PubMed ID: 33681386
[TBL] [Abstract][Full Text] [Related]
63. Effects of emodin on the demethylation of tumor-suppressor genes in pancreatic cancer PANC-1 cells.
Zhang H; Chen L; Bu HQ; Yu QJ; Jiang DD; Pan FP; Wang Y; Liu DL; Lin SZ
Oncol Rep; 2015 Jun; 33(6):3015-23. PubMed ID: 25891176
[TBL] [Abstract][Full Text] [Related]
64. Targeting cancer-related inflammation: Chinese herbal medicine inhibits epithelial-to-mesenchymal transition in pancreatic cancer.
Zhang J; Wang P; Ouyang H; Yin J; Liu A; Ma C; Liu L
PLoS One; 2013; 8(7):e70334. PubMed ID: 23922983
[TBL] [Abstract][Full Text] [Related]
65. [The relationship between the radioresistance of pancreatic cancer cell SW1990 and the induction of the Epithelial-Mesenchymal Transition: an in vitro study].
Jiang YH; You KY; Bi ZF; Li LT; Mo HQ; Liu YM
Zhonghua Yi Xue Za Zhi; 2018 Mar; 98(12):939-943. PubMed ID: 29665670
[No Abstract] [Full Text] [Related]
66. CP-31398 inhibits the progression of cervical cancer through reversing the epithelial mesenchymal transition via the downregulation of PAX2s.
Liu L; Yu TT; Ren CC; Yang L; Cui SH; Zhang XA
J Cell Physiol; 2019 Mar; 234(3):2929-2942. PubMed ID: 30132866
[TBL] [Abstract][Full Text] [Related]
67. Emodin reverses resistance to gemcitabine in pancreatic cancer by suppressing stemness through regulation of the epithelial‑mesenchymal transition.
Wei W; Wang J; Hu Y; Chen S; Liu J
Exp Ther Med; 2023 Jan; 25(1):7. PubMed ID: 36545274
[TBL] [Abstract][Full Text] [Related]
68. Synergistic effects of curcumin with emodin against the proliferation and invasion of breast cancer cells through upregulation of miR-34a.
Guo J; Li W; Shi H; Xie X; Li L; Tang H; Wu M; Kong Y; Yang L; Gao J; Liu P; Wei W; Xie X
Mol Cell Biochem; 2013 Oct; 382(1-2):103-11. PubMed ID: 23771315
[TBL] [Abstract][Full Text] [Related]
69. Silencing Tspan1 inhibits migration and invasion, and induces the apoptosis of human pancreatic cancer cells.
Tian J; Zhang R; Piao H; Li X; Sheng W; Zhou J; Dong M; Zhang X; Yan X; Shang W; Zhao J; Xu L; Liu F; Shi G
Mol Med Rep; 2018 Sep; 18(3):3280-3288. PubMed ID: 30066932
[TBL] [Abstract][Full Text] [Related]
70. KAP-1 is overexpressed and correlates with increased metastatic ability and tumorigenicity in pancreatic cancer.
Yu C; Zhan L; Jiang J; Pan Y; Zhang H; Li X; Pen F; Wang M; Qin R; Sun C
Med Oncol; 2014 Jul; 31(7):25. PubMed ID: 24861921
[TBL] [Abstract][Full Text] [Related]
71. Targeting CXCL5 in Pancreatic Cancer Cells Inhibits Cancer Xenograft Growth by Reducing Proliferation and Inhibiting EMT Progression.
Wang ZZ; Li XT; Li QJ; Zhou JX
Dig Dis Sci; 2023 Mar; 68(3):841-851. PubMed ID: 35650416
[TBL] [Abstract][Full Text] [Related]
72. ATP11A promotes EMT by regulating Numb PRR
Chen L; Tang J; Sheng W; Sun J; Ma Y; Dong M
PeerJ; 2022; 10():e13172. PubMed ID: 35345586
[TBL] [Abstract][Full Text] [Related]
73. Emodin exerts antitumor effects in ovarian cancer cell lines by preventing the development of cancer stem cells via epithelial mesenchymal transition.
Long H; Chen H; Yan J; Cheng H
Oncol Lett; 2022 Mar; 23(3):95. PubMed ID: 35154426
[TBL] [Abstract][Full Text] [Related]
74. Single-cell lineage tracing of metastatic cancer reveals selection of hybrid EMT states.
Simeonov KP; Byrns CN; Clark ML; Norgard RJ; Martin B; Stanger BZ; Shendure J; McKenna A; Lengner CJ
Cancer Cell; 2021 Aug; 39(8):1150-1162.e9. PubMed ID: 34115987
[TBL] [Abstract][Full Text] [Related]
75. Emodin attenuates high lipid-induced liver metastasis through the AKT and ERK pathways
Li F; Song X; Zhou X; Chen L; Zheng J
Heliyon; 2023 Jun; 9(6):e17052. PubMed ID: 37484373
[TBL] [Abstract][Full Text] [Related]
76. Identification of EMT-related alternative splicing event of TMC7 to promote invasion and migration of pancreatic cancer.
Weng Y; Qian H; Hong L; Zhao S; Deng X; Shen B
Front Immunol; 2022; 13():1089008. PubMed ID: 36713450
[TBL] [Abstract][Full Text] [Related]
77. Novel Compound C150 Inhibits Pancreatic Cancer Cell Epithelial-to-Mesenchymal Transition and Tumor Growth in Mice.
Wang T; Chen P; Dong R; Weir S; Baltezor M; Schoenen FJ; Chen Q
Front Oncol; 2021; 11():773350. PubMed ID: 34976816
[TBL] [Abstract][Full Text] [Related]
78. Emodin suppresses proliferation, migration and invasion in ovarian cancer cells by down regulating ILK in vitro and in vivo.
Lu J; Xu Y; Zhao Z; Ke X; Wei X; Kang J; Zong X; Mao H; Liu P
Onco Targets Ther; 2017; 10():3579-3589. PubMed ID: 28790850
[TBL] [Abstract][Full Text] [Related]
79. Anti-tumorigenic Effects of Emodin and Its' Homologue BTB14431 on Vascularized Colonic Cancer in a Rat Model.
Höhn P; Braumann C; Freiburger M; Koplin G; Dubiel W; Luu AM
Asian Pac J Cancer Prev; 2020 Jan; 21(1):205-210. PubMed ID: 31983185
[TBL] [Abstract][Full Text] [Related]
80. Emodin alleviates gemcitabine resistance in pancreatic cancer by inhibiting MDR1/P-glycoprotein and MRPs expression.
Guo H; Liu F; Yang S; Xue T
Oncol Lett; 2020 Nov; 20(5):167. PubMed ID: 32934734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
